Streetbeat News

Price Targets

FDMT

Chardan Capital analyst Geulah Livshits has reiterated a 'Buy' rating on 4D Molecular Therapeutics (NASDAQ:FDMT) and maintained a price target of $31.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 8:19 am

MGTX

Chardan Capital analyst Geulah Livshits has reiterated a 'Buy' rating on MeiraGTx Hldgs (NASDAQ:MGTX) and maintained a price target of $41.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 8:18 am

CRD

Barrington Research analyst Kevin Steinke has reiterated an 'Outperform' rating on Crawford & Company Common Stock (NYSE:CRD) and maintained a $14 price target.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 8:13 am

NXST

Barrington Research analyst James Goss has reiterated an 'Outperform' rating on Nexstar Media Gr (NASDAQ:NXST) and maintained a price target of $235.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 8:12 am

CLSK

Chardan Capital analyst Brian Dobson maintains a 'Buy' rating on Cleanspark (NASDAQ:CLSK) and raises the price target from $10 to $11.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 8:11 am

CYBR

Needham analyst Alex Henderson maintains a 'Buy' rating on CyberArk Software (NASDAQ:CYBR) and raises the price target from $185 to $190.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 8:10 am

PHAT

Needham analyst Joseph Stringer has reiterated a 'Buy' rating on Phathom Pharmaceuticals (NASDAQ:PHAT) and maintained a price target of $23.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 8:09 am

WKME

Needham analyst Scott Berg has reiterated a 'Buy' rating on WalkMe (NASDAQ:WKME) and maintained a price target of $20.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 8:08 am

FUBO

Needham analyst Laura Martin has reiterated a 'Buy' rating on FuboTV (NYSE:FUBO) and maintained a price target of $4.

Portfolio Pulse from richadhand@benzinga.com

August 11, 2023 | 8:06 am

DOOR

Stephens analyst Trey Grooms has reiterated an Overweight rating on Masonite International Corporation (NYSE:DOOR), raising the price target to $130 from $110. Despite a 3% decline in net sales in Q2 due to soft end-market demand, the company's EBITDA was ahead of expectations. The analyst expects Masonite's margins to expand due to cost reduction efforts and the realization of Endura acquisition synergies. However, the analyst has lowered sales estimates for Q3, FY23, and FY24 due to the challenging demand environment.

Portfolio Pulse from Nabaparna Bhattacharya

August 10, 2023 | 8:36 pm